Recommendations

Use this treatment:

It is effective in relieving runny nose (but does not unblock stuffy nose). Side effects are minor.

Doctors Say That

Note that while infections with various strains of Corona viruses are responsible for most cases of common cold, the new corona virus strain, SARS-CoV-2, leads to an entirely different coronavirus infectious disease, COVID-19. The research of treatments for COVID-19 is still pre mature and not based on solid evidence. Therefore, at this stage, we can only speculate that effective treatments for common cold (and related Corona virus strains) may prove effective for Corona disease 2019 (COVID-19) and the related SARS-CoV-2 strain. Please don't count on it.

About Ipratropium Bromide Nasal spray (RX)

Nasal spray

Target Population:

Adults with cold, 16 to 65 years old

Dosage:

Two sprays per nostril. Times per day (2-4) and daily dosage (168-672 mcg) vary with age, spray percentage (0.03% or 0.06%) and individual response.

Goal:

Treatment of Common Cold symptoms

Research Summary

Reasonably tested

7Clinical Studies

2,144 Adults Tested

Effective

Benefits:

Reliefs runny nose, but does not unblock stuffy nose.

Mild risks

Risks:

Minor reported side effects include dry nose, bloody mucus and bleeding from the nose.

Common Cold Overview

Medical problem:

Common Cold (symptoms caused by viral infection of the upper respiratory system).

Ipratropium bromide, sold under the trade name Atrovent among others, is a medication which opens up the medium and large airways in the lungs. It is used to treat the symptoms of chronic obstructive pulmonary disease and asthma. It is used by inhaler or nebulizer. Onset of action is typically within 15 to 30 minutes and lasts for three to five hours. Ipratropium bromide was developed in Germany in 1976. (source)